Table 1 Demographic, clinical, and laboratory characteristics of 181,804 patients on hemodialysis based on the dialyzer classification.

From: Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis

Variable

I a

II a

II b

S

P-value

n (%male)

102,992 (61.4)

64,155 (70.9)

4325 (76.1)

10,332 (57.1)

 < 0.0001

Age, years

71.1 ± 11.8

66.4 ± 12.1

63.3 ± 11.9

73.9 ± 11.2

 < 0.0001

Vintage, months

60 [27–120]

78 [37–144]

88 [43–165]

54 [24–107]

 < 0.0001

Cause of ESKD

 < 0.0001

 Diabetic nephropathy

39.8

39.7

36.6

39.8

 

 Chronic glomerulonephritis

28.7

31.6

35.7

27.3

 

 Nephrosclerosis

12.7

10.8

10.5

13.8

 

 Others

18.8

17.9

17.2

19.1

 

Diabetes mellitus, %

54.6

54.3

48.2

55.7

 < 0.0001

Comorbid CVD, %

35.4

31.8

29.1

37.7

 < 0.0001

Systolic BP, mmHg

150 ± 25

152 ± 24

152 ± 24

150 ± 26

 < 0.0001

Diastolic BP, mmHg

76 ± 14

79 ± 15

81 ± 15

76 ± 15

 < 0.0001

Heart rate, bpm

74 ± 13

75 ± 13

76 ± 13

74 ± 13

 < 0.0001

Body mass index, kg/m2

21.2 ± 3.8

22.4 ± 4.2

22.8 ± 4.2

20.7 ± 3.7

 < 0.0001

Serum urea nitrogen, mg/dL

59.8 ± 15.9

61.4 ± 15.4

61.5 ± 14.5

56.4 ± 16.2

 < 0.0001

Creatinine, mg/dL

9.3 ± 2.8

10.5 ± 2.7

11.0 ± 2.6

8.4 ± 2.7

 < 0.0001

β2-microglobulin, mg/L

27.0 ± 7.0

27.2 ± 6.3

27.6 ± 6.4

27.9 ± 8.3

 < 0.0001

Kt/V

1.45 ± 0.31

1.49 ± 0.30

1.52 ± 0.31

1.41 ± 0.31

 < 0.0001

Serum albumin, g/dL

3.5 ± 0.5

3.6 ± 0.4

3.6 ± 0.4

3.3 ± 0.5

 < 0.0001

Hemoglobin, g/dL

10.8 ± 1.3

11.0 ± 1.3

11.1 ± 1.3

10.6 ± 1.4

 < 0.0001

C-reactive protein, mg/dL

0.16 [0.06–0.52]

0.14 [0.05–0.42]

0.14 [0.06–0.39]

0.20 [0.07–0.68]

 < 0.0001

Calcium, mg/dL

8.7 ± 0.7

8.7 ± 0.7

8.7 ± 0.7

8.5 ± 0.8

 < 0.0001

Phosphate, mg/dL

5.1 ± 1.4

5.3 ± 1.5

5.5 ± 1.5

5.1 ± 1.5

 < 0.0001

Intact-PTH, pg/mL

126 [69–204]

136 [77–214]

140 [81–222]

123 [66–202]

 < 0.0001

  1. BP blood pressure, CVD cardiovascular disease, ESKD end-stage kidney disease, PTH parathyroid hormone.